An Integrated Fluorescent Biosensor, Imaging, and Analysis Toolkit for Islet Biologics
An Integrated Fluorescent Biosensor, Imaging, and Analysis Toolkit for Islet Biologics
批准号:
10200034
负责人:
Huiwang Ai
金额:
$40.38万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-07-01 至 2024-03-31
关键词:
AffectAmericanBeta CellBiologicalBiological AssayBiosensorCell LineCell TherapyCell secretionCellsCellular PhoneChemicalsClinicalCollectionColorComputer softwareCustomDevelopmentDiseaseEconomicsEncapsulatedEvaluationFamily suidaeFundingFutureGenerationsGlucoseGlutathione DisulfideGreen Fluorescent ProteinsHumanHypoxiaImageImmuneImmune responseImmunosuppressive AgentsInsulinInsulin-Dependent Diabetes MellitusIon ChannelIslets of LangerhansIslets of Langerhans TransplantationLeadMetabolicMetabolismMethodsMicrofluidicsMonitorMusNADPOrangesOrgan TransplantationOutcomeOxidation-ReductionPatientsPenetrationPhenotypePhototoxicityPhysiologicalPhysiological ProcessesPhysiologyPreparationProteinsQuality ControlResearchResearch PersonnelScreening procedureSecretory VesiclesSerotoninSignal TransductionSourceStandardizationSystemTissuesToxic effectTransplantationUnited States Food and Drug AdministrationWorkYouthallotransplantautocrinebasecell replacement therapydiabetes mellitus therapyfluorescence imagingfluorescence microscopegenetic elementglycemic controlhuman stem cellsimprovedin vitro Assayinnovationisletislet stem cellsmicroscopic imagingminimally invasivemultiplexed imagingnext generationnovelparacrinepublic health relevancered fluorescent proteinresearch clinical testingresponsesensorspatiotemporalstem cellssuccesssynergismtooltransplant centers
中文摘要
摘要
这个为期4年的R01项目的目标是开发一个创新和全面的工具包,包括
收集基于荧光蛋白(FP)的生物传感器、微流控芯片上的胰岛、智能手机
荧光显微镜和一种图像分析应用程序,为评估人类的潜能而优化
胰岛作为1型糖尿病(T1D)的基于细胞的治疗,以及用于表型和
未来T1D治疗的新兴生物制剂的生理学。
我们建议使用基因编码的荧光生物传感器来评估β的关键生理参数-
细胞和胰岛,并进一步确定各种有前景的生物制剂的效力、表型和生理学
用于T1D细胞替代疗法。利用我们强大团队的互补专业知识和我们广泛的
为了取得初步成果,我们将追求以下两个具体目标:
1.开发和优化荧光生物传感器,用于监测β细胞和胰岛的关键生理过程。
2.将生物传感器与微流控阵列、智能手机荧光显微镜、定制的
胰岛生物制品标准化、高含量表征的成像分析应用。
该项目的成果将是一个经济、综合的系统,方便可靠
人类胰岛、异种胰岛、被包裹的胰岛和干细胞来源的β细胞的特征。这些输入
体外试验创新性地评估了β细胞和胰岛的几个关键生理参数,不仅可以
可用于标准化和质量控制,也可作为改进世代的重要筛选工具,
储存和运输下一代生物制品。我们提议的工作将对以下方面产生重大影响
当前和未来糖尿病细胞替代疗法的发展。
英文摘要
Abstract
The objective of this 4-year R01 project is to develop an innovative and comprehensive toolkit, including a
collection of fluorescent protein (FP) based biosensors, a microfluidic Islet-On-a-Chip, a smartphone
fluorescence microscope, and an imaging analysis application, optimized for the potency evaluation of human
islets as cell-based therapy in Type 1 diabetes (T1D), as well as for characterization of the phenotype and
physiology of emerging new biologics for future T1D treatment.
We propose to use genetically encoded fluorescent biosensors to evaluate key physiological parameters of β-
cells and islets, and furthermore, to define the potency, phenotype, and physiology of various promising biologics
for T1D cell replacement therapy. Leveraging the complementary expertise of our strong team and our extensive
preliminary results, we will pursue the following two Specific Aims:
1. Develop and optimize fluorescent biosensors to monitor key physiological processes in β-cells and islets.
2. Integrate biosensors with microfluidic arrays, a smartphone fluorescence microscope, a customized
imaging analysis application for standardized, high-content characterization of islet biologics.
The outcome of this project will be an economic and integrated system for convenient and reliable
characterization of human islets, xenogeneic islets, encapsulated islets, and stem-cell-derived β-cells. These in
vitro assays, which innovatively evaluate several key physiological parameters of β-cells and islets, can not only
be used for standardization and quality control, but also be important screening tools to improve the generation,
storage, and transport of next-generation biologics. Our proposed work will generate significant impacts on
development of current and future cell replacement therapy for diabetes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Fluorescent Indicators for Imaging Synaptic Zinc in Cortical Sound Processing
-
批准号:10709627
-
项目类别:
-
资助金额:$66.88万
-
财政年份:2022
-
负责人:Huiwang Ai
-
依托单位:
Fluorescent Indicators for Imaging Synaptic Zinc in Cortical Sound Processing
-
批准号:10599603
-
项目类别:
-
资助金额:$68.42万
-
财政年份:2022
-
负责人:Huiwang Ai
-
依托单位:
An Integrated Fluorescent Biosensor, Imaging, and Analysis Toolkit for Islet Biologics
-
批准号:10613923
-
项目类别:
-
资助金额:$40.38万
-
财政年份:2020
-
负责人:Huiwang Ai
-
依托单位:
An Integrated Fluorescent Biosensor, Imaging, and Analysis Toolkit for Islet Biologics
-
批准号:10379407
-
项目类别:
-
资助金额:$40.38万
-
财政年份:2020
-
负责人:Huiwang Ai
-
依托单位:
Red and Far-Red Fluorescent Biosensors for Compartmentalized Redox Signaling
-
批准号:10222722
-
项目类别:
-
资助金额:$37.84万
-
财政年份:2018
-
负责人:Huiwang Ai
-
依托单位:
BapaFPs: Genetically encoded fluorescent indicators to image live-cell nucleotide sugars
-
批准号:9750256
-
项目类别:
-
资助金额:$47.43万
-
财政年份:2018
-
负责人:Huiwang Ai
-
依托单位:
Red and Far-Red Fluorescent Biosensors for Compartmentalized Redox Signaling
-
批准号:9975915
-
项目类别:
-
资助金额:$37.84万
-
财政年份:2018
-
负责人:Huiwang Ai
-
依托单位:
Lentiviral Systems for Controlled Mammalian Expression of Unnatural Fluorescent Protein Probes
-
批准号:8873037
-
项目类别:
-
资助金额:$7.6万
-
财政年份:2015
-
负责人:Huiwang Ai
-
依托单位:
海外基金